Literature DB >> 3803249

Penetration and concentration of cefadroxil in sputum, lung and pleural fluid.

C H Nightingale.   

Abstract

The penetrability of cefadroxil in sputum, pleural fluid and lung tissue was examined in patients with acute respiratory infections, or who were undergoing thoracic surgery. The concentration of antibiotic in these tissues after single doses of 500 mg or 1 g was approximately half of that seen in serum, but persisted longer. In all biological matter studied, the concentration of cefadroxil was sufficient to inhibit pathogens such as S. aureus, S. pneumoniae and S. pyogenes, shown to be common causes of respiratory illnesses. Thus, cefadroxil should be a useful agent in the treatment of such infections.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3803249     DOI: 10.2165/00003495-198600323-00004

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  6 in total

1.  Penetration of antimicrobial agents into bronchial secretions.

Authors:  G A Wong; T H Pierce; E Goldstein; P D Hoeprich
Journal:  Am J Med       Date:  1975-08       Impact factor: 4.965

2.  Comparative human oral clinical pharmacology of cefadroxil, cephalexin, and cephradine.

Authors:  M Pfeffer; A Jackson; J Ximenes; J P de Menezes
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

3.  Comparative pharmacokinetics of cephalexin, cefaclor, cefadroxil, and CGP 9000.

Authors:  H Lode; R Stahlmann; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

4.  Clinical pharmacology of cefadroxil in infants and children.

Authors:  C M Ginsburg; G H McCracken; J C Clahsen; M L Thomas
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

5.  Tissue and fluid concentrations of cefadroxil monohydrate.

Authors:  L L Bernhardt
Journal:  J Int Med Res       Date:  1980       Impact factor: 1.671

6.  Cefadroxil, a new broad-spectrum cephalosporin.

Authors:  R E Buck; K E Price
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

  6 in total
  2 in total

Review 1.  Considerations in dosage selection for third generation cephalosporins.

Authors:  J H Yuk-Choi; C H Nightingale; T W Williams
Journal:  Clin Pharmacokinet       Date:  1992-02       Impact factor: 6.447

2.  Physiologically Based Pharmacokinetic Modeling of Cefadroxil in Mouse, Rat, and Human to Predict Concentration-Time Profile at Infected Tissue.

Authors:  Zhongxia Tan; Youxi Zhang; Chao Wang; Le Sun
Journal:  Front Pharmacol       Date:  2021-12-23       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.